Specialty Pharmacy

Advancing biomarker research may help determine which patients with non-invasive breast cancer will develop invasive disease.

Novel gene therapy technique may lead to a long-term therapy against HIV.

Top news of the day from across the health care landscape.

Ribavirin steady-state serum levels correspond to high rates of efficacy and low adverse effect from direct-acting antiviral drugs for difficult-to-treat hepatitis C virus.

Matt Gillin, Chief Executive Officer, Relay Network, discusses what a crucial role technology plays in medication adherence.

New legislation would remove rules that prevent pharmacists from telling patients their prescriptions would be cheaper without insurance.

Eating processed meats may escalate breast cancer risk above 20%.

Cancer may slow down protein synthesis and alter circadian rhythm to avoid cell death.

A panel of multiple sclerosis experts recently modified the 2010 McDonald Criteria to improve the diagnostic process.

Top news of the day from across the health care landscape.

Landmark trial to evaluate the superiority of secukinumab for slowing spinal bone damage versus proposed biosimilar adalimumab.

Electronic prior authorization can reduce time to fill for specialty drugs.

Estrogen produced during pregnancy could reduce multiple sclerosis relapses by 70%.

Blueberries may act as a radiosensitizer that could reduce damage to healthy cells caused by traditional cancer treatments.

Implementing a one-time screening for HIV at age 25 may be a cost-effective way to identify new infections.

Top news of the day from across the health care landscape.

The path to a hepatitis C vaccine is yielded by the virus’ virulent nature and its evasiveness to immune responses.

Pharma companies struggle to find the right balance between rigid quality systems and risk-based flexible quality systems.

Marc O’Connor, chief operating officer, Curant Health discusses the role specialty pharmacists play in chronic disease management.

Atazanavir (Reytaz) is indicated to treat patients with an HIV-1 infection.

Drinking 4 or more cups of coffee per day slashed the risk of colorectal cancer-related mortality in half.

Conflicting breast cancer treatment guidelines can leave many decisions to the discretion of the provider.

Investigational JAK1-selective inhibitor may reduce the symptoms of atopic dermatitis.

Top news of the day from across the health care landscape.

Sofosbuvir/velpatasvir is the first direct acting antiviral therapy registered for use against all 6 genotypes of hepatitis C.

Cisplatin and platinum-based chemotherapies cause hearing loss in up to 80% of adults and more than 50% of children.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, analyzes the benefits of pharmacy benefit tools for patients with private and public insurance.

Unapproved stem cell therapies may cause patient harm with serious and life-threatening diseases.